View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Ibrutinib 420 / Rituximab (50,325), Chronic Lymphocytic Leukemia, cycle 2, first-line
Protocol-ID: 1326 V1.0 (Mini), IBRU420/RITU(50,325), CLL, C2, first-lineIndication(s)
- Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 06.09.2019